|
[1]
|
Immunohistochemical Expression Levels of Epidermal Growth Factor Receptor, Cyclooxygenase-2, and Ki-67 in Canine Cutaneous Squamous Cell Carcinomas
Current Issues in Molecular Biology,
2024
DOI:10.3390/cimb46050297
|
|
|
|
|
[2]
|
Immunostaining and gene expression of epidermal growth factor receptors (HER1/HER2) in canine cutaneous squamous cell carcinoma
Research in Veterinary Science,
2024
DOI:10.1016/j.rvsc.2024.105363
|
|
|
|
|
[3]
|
Canine squamous cell carcinoma: Electrochemotherapy association with surgery and correlation with overall survival
Veterinary and Comparative Oncology,
2023
DOI:10.1111/vco.12882
|
|
|
|
|
[4]
|
VEGF Expression, Cellular Infiltration, and Intratumoral Collagen Levels after Electroporation-Based Treatment of Dogs with Cutaneous Squamous Cell Carcinoma
Life,
2021
DOI:10.3390/life11121321
|
|
|
|
|
[5]
|
VEGF Expression, Cellular Infiltration, and Intratumoral Collagen Levels after Electroporation-Based Treatment of Dogs with Cutaneous Squamous Cell Carcinoma
Life,
2021
DOI:10.3390/life11121321
|
|
|
|
|
[6]
|
Electrochemotherapy induces tumor regression and decreases the proliferative index in canine cutaneous squamous cell carcinoma
Scientific Reports,
2019
DOI:10.1038/s41598-019-52461-6
|
|
|
|
|
[7]
|
Electrochemotherapy induces tumor regression and decreases the proliferative index in canine cutaneous squamous cell carcinoma
Scientific Reports,
2019
DOI:10.1038/s41598-019-52461-6
|
|
|
|
|
[8]
|
Epidemiology of tumors in dogs in the capital of the state of Mexico from 2002-2016
Arquivo Brasileiro de Medicina Veterinária e Zootecnia,
2019
DOI:10.1590/1678-4162-10534
|
|
|
|
|
[9]
|
Electrochemotherapy induces tumor regression and decreases the proliferative index in canine cutaneous squamous cell carcinoma
Scientific Reports,
2019
DOI:10.1038/s41598-019-52461-6
|
|
|
|
|
[10]
|
Correlation Between Cyclo-oxygenase-2 and Vascular Endothelial Growth Factor Expression in Canine and Feline Squamous Cell Carcinomas
Journal of Comparative Pathology,
2016
DOI:10.1016/j.jcpa.2016.02.005
|
|
|
|
|
[11]
|
Clinical outcome and cyclo-oxygenase-2 expression in five dogs with solar dermatitis/actinic keratosis treated with firocoxib
Veterinary Dermatology,
2013
DOI:10.1111/vde.12082
|
|
|
|
|
[12]
|
Clinical outcome and cyclo‐oxygenase‐2 expression in five dogs with solar dermatitis/actinic keratosis treated with firocoxib
Veterinary Dermatology,
2013
DOI:10.1111/vde.12082
|
|
|
|